Stay updated with breaking news from Tissue Matrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CEO Antony Koblish acquired 11,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were purchased at an average cost of $4.54 per share, with a total value of $49,940.00. Following the completion of the acquisition, the chief executive officer […]
TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CFO Roberto Cuca purchased 10,000 shares of TELA Bio stock in a transaction that occurred on Tuesday, November 14th. The stock was acquired at an average cost of $4.49 per share, with a total value of $44,900.00. Following the acquisition, the chief financial officer now directly owns […]
New addition expands reconstruction options for surgeons and patientsMALVERN, Pa., Aug. 16, 2023 -- TELA Bio, Inc. , a commercial-stage medical technology company focused on providing innovative... -Today at 07:02 am- MarketScreener
GlucoTrack (NASDAQ:GCTK – Get Rating) and TELA Bio (NASDAQ:TELA – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Risk & Volatility GlucoTrack has a beta of -1.13, indicating […]
Sanders Morris Harris LLC cut its holdings in TELA Bio, Inc. (NASDAQ:TELA – Get Rating) by 17.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 69,168 shares of the company’s stock after selling 14,200 shares during the quarter. Sanders Morris Harris LLC owned […]